AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29126173 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 26983976 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (once-per-day)
Number of subjects: 400
Study 26983976 — intervention group
Group type: COMPARATOR
Intervention: No topical corticosteroids
Number of subjects: 400
Study 24671338 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (sensitising dosage pattern)
Number of subjects: 0
Study 22464810 — intervention group
Group type: EXPERIMENTAL
Intervention: Golden Delicious apple juice (300 mL)
Number of subjects: 9
Study 22464810 — intervention group
Group type: EXPERIMENTAL
Intervention: Catarina apple juice (300 mL)
Number of subjects: 9
Study 22464810 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 9
Study 19827166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (LS)
Number of subjects: 31
Study 19827166 — intervention group
Group type: COMPARATOR
Intervention: Structured education (control)
Number of subjects: 31
Study 17823908 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel/gemcitabine (docetaxel 30 mg/m(2) + gemcitabine 800 mg/m(2))
Number of subjects: 350
Study 17823908 — intervention group
Group type: COMPARATOR
Intervention: Weekly docetaxel (36 mg/m(2))
Number of subjects: 350
Study 17823908 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel/gemcitabine
Number of subjects: 350
Study 17823908 — intervention group
Group type: COMPARATOR
Intervention: Weekly docetaxel
Number of subjects: 350
Study 15339495 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional steroid plus kidney-warming and astringent therapy (treatment group)
Number of subjects: 44
Study 15339495 — intervention group
Group type: COMPARATOR
Intervention: Conventional steroid treatment (control group)
Number of subjects: 44
Study 11691528 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-chamber pacemaker implant (paced patients)
Number of subjects: 175
Study 11691528 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (controls)
Number of subjects: 175
Study 9647418 — intervention group
Group type: EXPERIMENTAL
Intervention: BMT-plus-RP
Number of subjects: 59
Study 9647418 — intervention group
Group type: COMPARATOR
Intervention: BMT-only
Number of subjects: 59
Study 8016038 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail-out intervention for increasing screening mammography rates
Number of subjects: 802
Study 8016038 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 802
Study 8016038 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention and control group
Number of subjects: 802
Study 2801831 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol (600 mg/day)
Number of subjects: 0
Study 2801831 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (100 mg/day)
Number of subjects: 0
Study 2801831 — intervention group
Group type: COMPARATOR
Intervention: Conservative surgery plus danazol
Number of subjects: 0
Study 2801831 — intervention group
Group type: COMPARATOR
Intervention: Conservative surgery plus medroxyprogesterone acetate
Number of subjects: 0
Study 2801831 — intervention group
Group type: COMPARATOR
Intervention: Conservative surgery plus placebo
Number of subjects: 0
Study 2801831 — intervention group
Group type: COMPARATOR
Intervention: Conservative surgery
Number of subjects: 0
Study 2801831 — intervention group
Group type: COMPARATOR
Intervention: Mild endometriosis
Number of subjects: 0
Study 2801831 — intervention group
Group type: COMPARATOR
Intervention: Advanced endometriosis
Number of subjects: 0
Study 49745 — intervention group
Group type: EXPERIMENTAL
Intervention: Long 'Teflon' cannulas
Number of subjects: 0
Study 49745 — intervention group
Group type: EXPERIMENTAL
Intervention: Butterfly stainless steel cannulas
Number of subjects: 0
Study 49745 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent short duration intravenous infusions
Number of subjects: 0
Study 31376356 — intervention group
Group type: EXPERIMENTAL
Intervention: Maltodextrin-based feed with lysozyme product (Inovapure) at 20 g/kg
Number of subjects: 20
Study 31376356 — intervention group
Group type: EXPERIMENTAL
Intervention: Maltodextrin-based feed with lysozyme product (Inovapure) at 10 g/kg
Number of subjects: 20
Study 31376356 — intervention group
Group type: EXPERIMENTAL
Intervention: Maltodextrin-based feed with lysozyme product (Inovapure) at 0 g/kg
Number of subjects: 20
Study 31376356 — intervention group
Group type: COMPARATOR
Intervention: Traditional feed withdrawal
Number of subjects: 20
Study 29529607 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle block added to general anesthesia (group B)
Number of subjects: 60
Study 29529607 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia only (group A)
Number of subjects: 60
Study 26908424 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt Kplus (enriched with MK-7, vitamins D3 and C, magnesium, n-3 PUFA, and fish oil)
Number of subjects: 0
Study 26908424 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt K (fortified with MK-7 only)
Number of subjects: 0
Study 26908424 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft gel capsules containing MK-7
Number of subjects: 0
Study 26908424 — intervention group
Group type: COMPARATOR
Intervention: Yogurt Kplus
Number of subjects: 0
Study 26908424 — intervention group
Group type: COMPARATOR
Intervention: Yogurt K
Number of subjects: 0
Study 26908424 — intervention group
Group type: COMPARATOR
Intervention: Soft gel capsules
Number of subjects: 0
Study 25266313 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive warming mattress
Number of subjects: 116
Study 25266313 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 116
Study 23185760 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo Biloba Tablet (GBT), 1 tablet each time, 3 times a day for 12 months
Number of subjects: 113
Study 23185760 — intervention group
Group type: COMPARATOR
Intervention: Control group (basic treatment only)
Number of subjects: 113
Study 19829141 — intervention group
Group type: EXPERIMENTAL
Intervention: Local intracoronary infusion of abciximab through the ClearWayRX System
Number of subjects: 0
Study 19829141 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary infusion of abciximab via the guiding catheter
Number of subjects: 0
Study 19829141 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups receive intravenous infusion of abciximab during the 12‐h period following the procedure
Number of subjects: 0
Study 17608573 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment (160 mJ/pulse at 10 Hz)
Number of subjects: 25
Study 17608573 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic scaler treatment
Number of subjects: 25
Study 16232156 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMT)
Number of subjects: 49
Study 16232156 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 49
Study 12122527 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion
Number of subjects: 11
Study 11261739 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg/die administered at 10.00 PM
Number of subjects: 40
Study 11261739 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg/die administered at 8.00 AM
Number of subjects: 40
Study 11261739 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg/die administered at 4.00 PM
Number of subjects: 40
Study 11261739 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg/die administered at night (10.00 PM)
Number of subjects: 40
Study 7717566 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MAC isoflurane
Number of subjects: 28
Study 7717566 — intervention group
Group type: COMPARATOR
Intervention: 1 MAC enflurane
Number of subjects: 28
Study 1961957 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol induction (2.5 mg/kg)
Number of subjects: 40
Study 1961957 — intervention group
Group type: COMPARATOR
Intervention: Thiopental induction (4-5 mg/kg)
Number of subjects: 40
Study 7017018 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective appendectomy at the time of transplantation
Number of subjects: 75
Study 7017018 — intervention group
Group type: EXPERIMENTAL
Intervention: Profound lymphocytopenia
Number of subjects: 75
Study 31735238 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSAAF program
Number of subjects: 346
Study 27789177 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gluconate mouthwash (n=23)
Number of subjects: 43
Study 27789177 — intervention group
Group type: COMPARATOR
Intervention: Octenidine-based, chlorhexidine-free mouthwash (n=20)
Number of subjects: 43
Study 25502610 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated counseling website
Number of subjects: 97
Study 25502610 — intervention group
Group type: COMPARATOR
Intervention: Standard website
Number of subjects: 97
Study 24480156 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test (CPT) in non-smokers
Number of subjects: 20
Study 24480156 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test (CPT) in smokers
Number of subjects: 20
Study 24480156 — intervention group
Group type: COMPARATOR
Intervention: Resting MBF in smokers
Number of subjects: 20
Study 22137859 — intervention group
Group type: EXPERIMENTAL
Intervention: Capillary blood sampling using the Chempaq Express Blood Counter (point-of-care device)
Number of subjects: 85
Study 22137859 — intervention group
Group type: COMPARATOR
Intervention: Traditional venous blood sampling
Number of subjects: 85
Study 20310020 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g mesalamine suppository once daily
Number of subjects: 354
Study 20310020 — intervention group
Group type: COMPARATOR
Intervention: 0.5 g mesalamine suppository thrice daily
Number of subjects: 354
Study 17903638 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 8695
Study 17903638 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 8695
Study 15848517 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) introduced instead of azathioprine (AZA) in group 1 (n = 17)
Number of subjects: 35
Study 15848517 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA) maintained in group 2 (n = 18)
Number of subjects: 35
Study 15848517 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MMF and AZA)
Number of subjects: 35
Study 15848517 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversion of AZA to MMF
Number of subjects: 35
Study 12150347 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% triacylglycerol emulsion (500 ml, 450 Kcal)
Number of subjects: 30
Study 12150347 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% triacylglycerol emulsion (500 ml, 900 Kcal)
Number of subjects: 30
Study 10379369 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-fentanyl
Number of subjects: 30
Study 10379369 — intervention group
Group type: COMPARATOR
Intervention: Midazolam-fentanyl
Number of subjects: 30
Study 7597305 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy with IFN alpha and high-dose IL-2
Number of subjects: 45
Study 7597305 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy with dacarbacine (DTIC) followed by IFN-alpha
Number of subjects: 45
Study 7597305 — intervention group
Group type: COMPARATOR
Intervention: Single dose of DTIC or cisplatinum (CDDP) followed by IFN-alpha/IL-2
Number of subjects: 45
Study 1972927 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg astemizole
Number of subjects: 105
Study 1972927 — intervention group
Group type: COMPARATOR
Intervention: 10 mg cetirizine
Number of subjects: 105
Study 6975997 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenprocoumon (oral anticoagulant therapy)
Number of subjects: 174
Study 6975997 — intervention group
Group type: COMPARATOR
Intervention: Control group (no oral anticoagulant therapy)
Number of subjects: 174
Study 30685831 — intervention group
Group type: EXPERIMENTAL
Intervention: Information-based hospital-family integration continuous care model (WeChat, blog, QQ, telephone, etc.)
Number of subjects: 155
Study 30685831 — intervention group
Group type: COMPARATOR
Intervention: Routine standard of care
Number of subjects: 155
Study 31856909 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks)
Number of subjects: 30
Study 31856909 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks) plus Denosumab (120 mg every 2 weeks, following nivolumab)
Number of subjects: 30
Study 28663610 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 100
Study 28663610 — intervention group
Group type: COMPARATOR
Intervention: 1% lignocaine
Number of subjects: 100
Study 25895016 — intervention group
Group type: EXPERIMENTAL
Intervention: CDS (computerized clinical decision support)
Number of subjects: 549
Study 25895016 — intervention group
Group type: EXPERIMENTAL
Intervention: CDS + coaching
Number of subjects: 549
Study 25895016 — intervention group
Group type: EXPERIMENTAL
Intervention: CDS
Number of subjects: 549
Study 25895016 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 549
Study 23559221 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 93
Study 23559221 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief of consuming glucose
Number of subjects: 93
Study 23559221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 17601194 — intervention group
Group type: EXPERIMENTAL
Intervention: Wilmington robotic exoskeleton (WREX)
Number of subjects: 17
Study 17601194 — intervention group
Group type: COMPARATOR
Intervention: Without WREX
Number of subjects: 17
Study 15082280 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline (5 mg/kg intravenously after induction, maintained with 0.5 mg/kg per hour)
Number of subjects: 30
Study 15082280 — intervention group
Group type: COMPARATOR
Intervention: Control (no aminophylline)
Number of subjects: 30
Study 10921758 — intervention group
Group type: EXPERIMENTAL
Intervention: HFA‐BDP 400 microg day(‐1)
Number of subjects: 150
Study 10921758 — intervention group
Group type: COMPARATOR
Intervention: CFC‐BDP 1000 microg day(‐1)
Number of subjects: 150
Study 8957982 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate 0.3 mol litre‐1 (antacid)
Number of subjects: 20
Study 8957982 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate dehydrate (100 mg ml‐1) with citric acid monohydrate (66 mg ml‐1) (buffer)
Number of subjects: 20
Study 8957982 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gastric solution)
Number of subjects: 20
Study 7687142 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight hydroxyethyl starch solution (LMW‐HES) (6% HES; mean molecular weight 200,000 Da, molar substitution 0.5)
Number of subjects: 30
Study 7687142 — intervention group
Group type: COMPARATOR
Intervention: 20% albumin (HA)
Number of subjects: 30
Study 3698726 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose mezlocillin (5 grams preoperative)
Number of subjects: 163
Study 3698726 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose mezlocillin (3 doses of 2 grams perioperative)
Number of subjects: 163
Study 3698726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study 30414284 — intervention group
Group type: EXPERIMENTAL
Intervention: OIT with pasteurized egg white (PEW) - daily 3.3 g proteins (AG)
Number of subjects: 101
Study 30414284 — intervention group
Group type: EXPERIMENTAL
Intervention: OIT with pasteurized egg white (PEW) - every two days (BG)
Number of subjects: 101
Study 30414284 — intervention group
Group type: EXPERIMENTAL
Intervention: OIT with pasteurized egg white (PEW)
Number of subjects: 101
Study 30414284 — intervention group
Group type: COMPARATOR
Intervention: Egg-free diet (CG)
Number of subjects: 101
Study 27314148 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine heated to body temperature (37°C)
Number of subjects: 36
Study 27314148 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine at room temperature (21°C)
Number of subjects: 36
Study 27314148 — intervention group
Group type: COMPARATOR
Intervention: Cold lidocaine (8°C)
Number of subjects: 36
Study 25823635 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis cessation intervention
Number of subjects: 112
Study 25823635 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory analysis of cannabis use
Number of subjects: 112
Study 22882698 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed (500 mg/m²) plus cisplatin (75 mg/m²)
Number of subjects: 251
Study 22882698 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine (1000 mg/m² on days 1 and 8) plus cisplatin (75 mg/m²)
Number of subjects: 251
Study 22882698 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed/cisplatin
Number of subjects: 251
Study 22882698 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed-platinum (meta-analysis)
Number of subjects: 251
Study 21129053 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery rehearsal
Number of subjects: 198
Study 21129053 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure
Number of subjects: 198
Study 21129053 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 198
Study 21129053 — intervention group
Group type: COMPARATOR
Intervention: Nightmare recording group
Number of subjects: 198
Study 19644646 — intervention group
Group type: EXPERIMENTAL
Intervention: ProLoop plug (Atrium)
Number of subjects: 295
Study 19644646 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfix plug (Bard)
Number of subjects: 295
Study 19644646 — intervention group
Group type: EXPERIMENTAL
Intervention: Lichtenstein tension free mesh repair (LTFM)
Number of subjects: 295
Study 16675380 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational poster intervention during the poster month
Number of subjects: 720
Study 16675380 — intervention group
Group type: COMPARATOR
Intervention: Historical control periods (3 months prior)
Number of subjects: 720
Study 15260907 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of 5-hydroxytryptophan (5-HTP)
Number of subjects: 32
Study 15260907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 15260907 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of 5-hydroxytryptophan (5-HTP) in females
Number of subjects: 32
Study 15260907 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of 5-hydroxytryptophan (5-HTP) in males
Number of subjects: 32
Study 11416734 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured treatment interruptions (STI) in 12 patients
Number of subjects: 26
Study 11416734 — intervention group
Group type: COMPARATOR
Intervention: Non-interrupters (continued HAART) in 14 patients
Number of subjects: 26
Study 9316536 — intervention group
Group type: COMPARATOR
Intervention: VVI pacing at the same average rate as during intrinsically conducted AF (102 ± 22 beats/min)
Number of subjects: 16
Study 9316536 — intervention group
Group type: EXPERIMENTAL
Intervention: Irregular sequence of RR intervals
Number of subjects: 16
Study 8361472 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg per day added to immuno-chemotherapy (Tegaful, Mitomycin, Krestin, OK-432)
Number of subjects: 27
Study 8361472 — intervention group
Group type: COMPARATOR
Intervention: Non-Tamoxifen group (14 cases)
Number of subjects: 27
Study 8361472 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen in cases with estrogen receptor
Number of subjects: 27
Study 8361472 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen in cases without estrogen receptor
Number of subjects: 27
Study 3518464 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.25% and 0.5%
Number of subjects: 38
Study 3518464 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 38
Study 3518464 — intervention group
Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 38
Study 29433275 — intervention group
Group type: EXPERIMENTAL
Intervention: Low voltage electrical stimulation (LVES) for 30s at 7min post-mortem
Number of subjects: 26
Study 26967206 — intervention group
Group type: EXPERIMENTAL
Intervention: ACC-001 + QS-21
Number of subjects: 245
Study 26967206 — intervention group
Group type: COMPARATOR
Intervention: ACC-001
Number of subjects: 245
Study 26967206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study 24764496 — intervention group
Group type: EXPERIMENTAL
Intervention: Partners in Dementia Care (PDC)
Number of subjects: 508
Study 24764496 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 508
Study 21760633 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 250
Study 21760633 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 250
Study 21760633 — intervention group
Group type: COMPARATOR
Intervention: Treatment preference
Number of subjects: 250
Study 20060863 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein/low carbohydrate (HP/LC) breakfast
Number of subjects: 21
Study 20060863 — intervention group
Group type: COMPARATOR
Intervention: Low protein/high carbohydrate (LP/HC) breakfast
Number of subjects: 21
Study 17902001 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (‐TRP)
Number of subjects: 16
Study 17902001 — intervention group
Group type: COMPARATOR
Intervention: Control (+TRP)
Number of subjects: 16
Study 15644831 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma intervention
Number of subjects: 299
Study 15644831 — intervention group
Group type: COMPARATOR
Intervention: Control group (undiagnosed)
Number of subjects: 299
Study 15228241 — intervention group
Group type: EXPERIMENTAL
Intervention: ITNs and SP
Number of subjects: 752
Study 15228241 — intervention group
Group type: COMPARATOR
Intervention: ITNs and placebo SP
Number of subjects: 752
Study 15228241 — intervention group
Group type: EXPERIMENTAL
Intervention: SP alone
Number of subjects: 752
Study 15228241 — intervention group
Group type: COMPARATOR
Intervention: placebo SP
Number of subjects: 752
Study 10551571 — intervention group
Group type: COMPARATOR
Intervention: Sham TENS (no stimulation)
Number of subjects: 100
Study 10551571 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency (2-Hz) TENS
Number of subjects: 100
Study 10551571 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency (100-Hz) TENS
Number of subjects: 100